Health Costs

Affordable care act

Poll: Health Care Costs, Expiring ACA Tax Credits, and the 2026 Midterms

Heading into this midterm election year, the cost of health care tops the public’s economic anxieties, and more than 4 in 10 voters say the issue will have a major impact on their vote, a new KFF Health Tracking poll finds. Two thirds of public say Congress "did the wrong thing" by not extending ACA enhanced tax credits, but Republicans largely say Congress “did the right thing.”

Affordability and Spending

Our Darwinian Approach to Health Care Costs

Our Darwinian Approach to Health Care Costs

In his latest column, President and CEO Dr. Drew Altman presents his Venn diagram of health care cost problems and shows how, in our fragmented health system, reducing one health cost problem often makes another worse. "...Reducing health care costs has become a Darwinian game; everyone wants to reduce health care costs and spending – their own, often at the expense of someone else."

KEY RESOURCES
  • Health Policy 101: Costs and Affordability

    This Health Policy 101 chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies and the impact on affordability and people's overall financial vulnerability.  


  • Americans’ Challenges with Health Care Costs

    This data note reviews our recent polling data that finds that Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.

  • National Health Spending Explorer

    This interactive Peterson-KFF Health System Tracker tool allows users to examine five decades worth of data on health expenditures by federal and local governments, private insurers, and individuals.

  • Polling on Prescription Drugs and Their Prices

    This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

901 - 910 of 1,552 Results

  • Consumer Assets and Patient Cost Sharing

    Issue Brief

    Higher cost sharing in private insurance has been credited with helping to slow the growth of health care costs in recent years. For families with low incomes or moderate incomes, however, high deductibles, out-of-pocket limits and other cost sharing can be a potential barrier to care and may lead these families to significant financial difficulties. This issue brief uses information from the Federal Reserve Board's 2013 Survey of Consumer Finances to look at how household resources match up against potential cost-sharing requirements for plans offered by employers or available in the individual market, including in the Affordable Care Act marketplaces.

  • The Diseases We Spend Our Health Dollars On

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman explains how a recent Bureau of Economic Analysis report makes the nation’s health care spending more tangible by breaking it down by disease. All previous columns by Drew Altman are available online.

  • Americans Don’t Feel the Slowdown in Health Costs

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why the health policy agenda may shift to focus more on affordability of coverage, consumer protection and consumer information in coming years.

  • Why Low Growth in Health Costs Still Stings

    From Drew Altman

    This was published as a Wall Street Journal Think Tank column on April 8, 2015. In my last Think Tank piece, I reported that just 3% of Americans felt health costs had been rising more slowly than usual, even though they have been growing at record low rates in recent years.

  • Assessing the Performance of the U.S. Health System

    Issue Brief

    Health spending growth has consistently outpaced U.S. economic growth and is higher than medical spending in other wealthy countries. Despite spending more, the United States doesn't have better health outcome in terms of life expectancy, mortality rates and other measures. This brief provides an overview of trends in health costs and the performance of the U.S. health system, including comparisons to countries from the Organisation for Economic Co-operation and Development (OECD). The brief charts growth in the nation's per capita health spending along with the recent slowdown, touching on the roles of expanded Medicaid eligibility, increases in Medicare beneficiaries and the Affordable Care Act (ACA). Additionally, it discusses the health system's effectiveness and capacity to provide services, including the accessibility and affordability of care.

  • How Does U.S. Life Expectancy Compare to Other Countries?

    Feature

    This chart collection examines how life expectancy in the U.S. compares to that of other similarly large and wealthy countries. Between 2019 and 2022, the U.S. experienced a sharper decline and a slower rebound in life expectancy than peer countries, on average, due to increased mortality and premature death rates in the U.S. from the COVID-19 pandemic. In 2023, life expectancy in the U.S. returned to pre-pandemic levels, but remains lower than that of comparable countries.

  • How do mortality rates in the U.S. compare to other countries?

    Feature

    This slideshow compares mortality rates in the United States and other industrialized countries for seven major causes of death. The data show that U.S. mortality rates for circulatory diseases and cancer have fallen in the past 30 years, driving a decline in the nation's overall rate. However, mortality rates for leading causes of death other than cancer are higher in the United States than the average for comparable countries.

  • How do U.S. healthcare resources compare to other countries?

    Feature

    This slideshow examines the U.S. health care system and its resources in comparison with other industrialized countries. The data examine the relative number of hospital beds, doctors and nurses in the U.S. and other countries, as well as the availability and use of MRI machines as an example of medical technology.

  • Our Fragmented Approach to Health-Care Costs

    From Drew Altman

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses this week's Centers for Medicare and Medicaid Services report on health spending and assesses the current effort to control health-care costs.